Advertisement

Cardiologie pp 197-202 | Cite as

23 Percutane coronaire interventies

  • B. De Bruyne
  • G. R. Heyndrickx
  • P. W. Serruys
Part of the Quintessens book series (QUI)

Samenvatting

Myocardrevascularisatie blijft de belangrijkste doelstelling bij de behandeling van patiënten met obstructief coronairlijden, omdat duidelijk is aangetoond dat deze behandelingsvorm, meer nog dan de medicamenteuze behandeling, behalve de symptomen, in bepaalde groepen ook de prognose verbetert. In tegenstelling tot de klassieke coronaire bypassoperatie (CABG) beoogt men met een percutane coronaire interventie (PCI) langs niet-invasieve weg rechtstreeks de coronaire vernauwingen op te heffen. De techniek werd in 1977 geïntroduceerd door Gruentzig in Zürich. Tien jaar later werd op een controleangiogram aangetoond dat de gedilateerde coronaire arterie mooi open was. Geen enkele therapeutische interventie in de cardiologie heeft in zo korte tijd een zo snelle evolutie gekend als PCI. In de meeste westerse landen overtreft het aantal PCI’s dat per jaar wordt uitgevoerd het aantal CABG’s, en dit verschil neemt nog steeds toe.

Literatuur

  1. Colombo A, Hall P, Nakamura S, et al. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation. 1995;91:1676–88.PubMedCrossRefGoogle Scholar
  2. Colombo A, Moses JW, Morice MC, et al. Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions. Circulation. 2004;109:1244–9.PubMedCrossRefGoogle Scholar
  3. Fischman DL, Leon MB, Baim DS, et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med. 1994;331:496–501.PubMedCrossRefGoogle Scholar
  4. Grüntzig AR, Senning Å, Siegenthaler WE. Nonoperative dilatation of coronary artery stenosis: percutaneous transluminal coronary angioplasty. N Engl J Med. 1979;301:61–8.PubMedCrossRefGoogle Scholar
  5. Hoye A, Tanabe K, Lemos PA, et al. Significant reduction in restenosis after the use of sirolimus-eluting stents in the treatment of chronic total occlusions. J Am Coll Cardiol. 2004;43:1954–8.PubMedCrossRefGoogle Scholar
  6. Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA. 2005;293:2126–30.PubMedCrossRefGoogle Scholar
  7. McFadden EP, Stabile E, Regar E, et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet. 2004;364:1519–21.PubMedCrossRefGoogle Scholar
  8. Morice M-C, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 2002;346:1773–80.PubMedCrossRefGoogle Scholar
  9. Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003;349:1315–23.PubMedCrossRefGoogle Scholar
  10. Ong AT, Serruys PW, Mohr FW, et al. The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: design, rationale, and run-in phase. Am Heart J. 2006;151:1194–204.PubMedCrossRefGoogle Scholar
  11. Pijls NH, Bruyne B de, Peels K, Voort PH van der, Bonnier HJ, Bartunek J, et al. Measurement of fractional flow reserve to assess the functional severity of coronary-artery-stenoses. N Engl J Med. 1996; 334:1703–8.PubMedCrossRefGoogle Scholar
  12. Serruys PW, Jaegere P de, Kiemeneij F, et al. A comparison of balloon-expandable stent implantation with balloon angioplasty, in patients with coronary artery disease. N Engl J Med. 1994;331:489–95.PubMedCrossRefGoogle Scholar
  13. Serruys PW, Ong ATL, Herwerden LA van, et al. Five year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial. J Am Coll Cardiol. 2005;46:575–81.PubMedCrossRefGoogle Scholar
  14. Serruys PW, Ong ATL, Morice M-C, et al. Arterial Revascularisation Therapies Study II: sirolimus-eluting stents for the treatment of patients with multivessel de novo coronary artery lesions. Eurointervention 2005;1:147–56.PubMedGoogle Scholar
  15. Serruys PW, Unger F, Sousa JE, et al. Comparison of coronary artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med. 2001;344:1117–24.PubMedCrossRefGoogle Scholar
  16. Stone GW, Ellis SG, Cox DA, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med. 2004;350:221–31.PubMedCrossRefGoogle Scholar
  17. Zijlstra F, Boer MJ de, Hoorntje J, Reiffers S, Reiber J, Suryapranata HA. Comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med. 1993;328:680–4.PubMedCrossRefGoogle Scholar

Copyright information

© Bohn Stafleu van Loghum, Houten 2008

Authors and Affiliations

  • B. De Bruyne
    • 1
  • G. R. Heyndrickx
    • 1
  • P. W. Serruys
    • 2
  1. 1.Cardiovascular Center Aalst, Onze-Lieve-VrouwziekenhuisAalst
  2. 2.Erasmus UniversiteitRotterdam

Personalised recommendations